Dr. William Lane Verlenden, MD

Dr. Verlenden practices at Community Hospital of the Monterey Peninsula in Monterey, California, part of Montage Health.

Dr. Verlenden's NPI, 1912979642, was assigned on February 6, 2006. Dr. Verlenden graduated from Harvard Medical School in 1971. Dr. Verlenden's California license number on file is G23505.

Dr. Verlenden's primary practice is Community Hospital of the Monterey Peninsula, at 23625 W R Holman Highway, Monterey, CA 93940 in Monterey County. The practice phone is (831) 624-5311.

Dr. Verlenden's primary practice is Community Hospital of the Monterey Peninsula in Monterey, California, part of Montage Health. The medical group on file is Montage Medical Group. Dmand AI also links Dr. Verlenden to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verlenden practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Verlenden's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Verlenden is board certified in internal medicine by the American Board of Internal Medicine. Dr. Verlenden has a license on file in California.

Dmand AI lists amputation, aortic atherosclerois, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT) and peripheral vascular disease among the conditions Dr. Verlenden treats.

CMS data shows 1,445 Medicare services from Dr. Verlenden across 14 procedure codes in 2024, for 643 Medicare patients. Medicare paid $88,975 for them.

CMS counts 643 Medicare patients who saw Dr. Verlenden in 2024. The largest group is 75 to 84, with 271 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Verlenden's median patient age at 74, with 49% women.

In 2024, Dr. Verlenden wrote 201 Medicare Part D claims for 93 patients. 97% of them were for generic drugs. CMS names the drug for 115 of them, across 4 drugs with 11 or more claims each, at $2,341 in total drug cost. In 2023, CMS named 94 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Verlenden for performance year 2024, reported as part of a group. Dr. Verlenden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of hernia repair (minimally invasive) by Dr. Verlenden, more than 72% of the clinicians it reports for that procedure.

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 7 general payments to Dr. Verlenden from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. HeartFlow, Inc. paid the most, $165.

Dmand AI lists 1 award for Dr. Verlenden, most recently CMS Stage 1 2012 in 2012.

Dr. Verlenden graduated from Harvard Medical School in 1971.

Dr. Verlenden is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.